Clinical Trial

A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-10.
Trial Details
NCT Number NCT06878170
Lead Sponsor Rock BioMedical, Inc.
Conditions COVID-19
Enrollment 60 participants
Start Date 2024-09-30
Primary Completion 2025-05-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-08